Sponsor Pipeline

Asrar Alahmadi Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07423585 Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer Extensive Stage Lung Small Cell Carcinoma Recruiting
Disease Areas
Small Cell Lung Cancer (1)
Get alerts when Asrar Alahmadi's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free